ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
Several studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if...
Main Authors: | Thierry Jardé, Lisa Kass, Margaret Staples, Helen Lescesen, Peter Carne, Karen Oliva, Paul J McMurrick, Helen E Abud |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4569358?pdf=render |
Similar Items
-
Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
by: Christine Koulis, et al.
Published: (2020-03-01) -
The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients.
by: Raymond Yap, et al.
Published: (2016-01-01) -
Surgical Techniques for Abdominoperineal Resection for Rectal Cancer: One Size Does Not Fit All
by: Simon Wilkins, et al.
Published: (2022-02-01) -
Stromal Niche Signals That Orchestrate Intestinal RegenerationSummary
by: Helen E. Abud, et al.
Published: (2024-01-01) -
Microarray profiling to analyze the effect of Snai1 loss in mouse intestinal epithelium
by: Gary R. Hime, et al.
Published: (2015-09-01)